Showing results (281-290 of 606) with videos related to
Sort By:
Pageof 61
Pharmacoeconomics - Open|November 28, 2024
The Association between COVID-19 Status and Economic Costs in the Early Stages of the COVID-19 Pandemic: Evidence from a UK Symptom Surveillance Digital SurveySung Wook Kim, Caterina Alacevich, Catia Nicodemo, et al.Pharmacoeconomics - Open|May 24, 2026
Validation of the Obesity Lifecycle Model Built to Assess the Cost Effectiveness of Novel Therapies in the Management of ObesityBen Modley, Ahmed Seddik, Marc Evans, et al.Pharmacoeconomics - Open|March 2, 2026
Cost Effectiveness of the Adjuvanted Recombinant Zoster Vaccine in Older Adults in PortugalEleftherios Zarkadoulas, Fábio Silva, Joana Alves, et al.Pharmacoeconomics - Open|July 22, 2023
Highly Purified Human Menopausal Gonadotropin (HP-hMG) Versus Recombinant Follicle-Stimulating Hormone (rFSH) for Controlled Ovarian Stimulation in US Predicted High-Responder Patients: A Cost-Comparison AnalysisAndrew Khair, Tray Brown, Marie Markert, et al.Pharmacoeconomics - Open|June 12, 2023
Cost-Effectiveness Analysis of Siltuximab for Australian Public Investment in the Rare Condition Idiopathic Multicentric Castleman DiseaseFrancis Shupo, Keith R Abrams, Zanfina Ademi, et al.Pharmacoeconomics - Open|May 3, 2026
Advancing Lost Productivity Measurement in Economic Evaluations: Evidence Priorities from a Targeted Literature Review and Expert WorkshopR Brett McQueen, Benjamin Cohen, Caroline Kacergis, et al.Pharmacoeconomics - Open|March 30, 2026
Prevalence and Healthcare Costs of Metabolic Disorders Among Individuals with Schizophrenia Following Initiation of Oral Antipsychotic TherapyJoseph Tkacz, Alejandro Cajigal, Matthew Sidovar, et al.Pharmacoeconomics - Open|November 11, 2021
Community Distribution of Naloxone: A Systematic Review of Economic EvaluationsNelda Cherrier, Joanne Kearon, Robin Tetreault, et al.Pharmacoeconomics - Open|August 3, 2018
Measuring the Benefits of Decision Aids for Economic EvaluationThomas ButtPharmacoeconomics - Open|January 10, 2021
National Healthcare Economic Evaluation Guidelines: A Cross-Country ComparisonDeepshikha Sharma, Arun Kumar Aggarwal, Laura E Downey, et al.Pageof 61